Immunotherapy
"Anti-Tumor Effectiveness of Electrochemotherapy with Bleomycin Is Increased by TNF-alpha on SA-1 Tumors in Mice."
Published in Cancer Weekly, July 7th, 1997
According to the authors' abstract of an article published in Cancer Letters, "With the aim to increase anti-tumor effectiveness of electrochemotherapy, adjuvant immunotherapy with tumor necrosis factor-alpha (TNF-alpha) was tested on tumors in mice. Increased anti-tumor effectiveness on SA-1 tumors was observed after combining TNF-alpha, injected either intratumorally or peritumorally, with electrochemotherapy using suboptimal dose of bleomycin (BLM). The increased anti-tumor effectiveness was neither the result of potentiated anti-tumor effectiveness of TNF-alpha due to exposure of tumors to electric pulses, nor due to interaction with BLM. Therefore, the effect of adjuvant TNF-alpha...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-07-07)
More Articles from Cancer Weekly
- Cancer Gene Therapy (p53)
Prostate Cancer Succumbs to Adenovirus-Mediated Therapy - AIDS Vaccines
Recombinant Multi-Antigen TBC-3B Vaccine Trial Commences - Blood Safety
Physicians Advocate Procedures To Improve Surgical Blood Transfusion - Brain Cancer
FDA Clearance for Photon Radiosurgery System Announced - Breast Cancer
Wisconsin GOP Approves Breast Reconstruction Insurance Coverage - Breast Cancer (Diagnostics)
Blood Test Detects Recurrent Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
